Quick Facts: Therapeutic Domains

• Type 2 Diabetes: Used to assist in blood sugar regulation in individuals with Type 2 Diabetes Mellitus.
• Metabolic Management: May be an appropriate approach to address the challenges of high blood sugar when diet and activity changes alone are not sufficient.
• Combination Use: Often utilized alongside other compounds as part of a comprehensive management strategy.

---

Diamed is a compound intended to address the challenges associated with the management of blood glucose levels in adults diagnosed with Type 2 Diabetes Mellitus. Its primary therapeutic goal is to assist in achieving appropriate blood sugar regulation as part of an overall diabetes care plan.

This medication is typically utilized when nutritional and physical activity interventions, which are foundational for diabetes management, have not resulted in desired glycemic targets. Its inclusion in a care plan may support efforts to maintain blood glucose within acceptable ranges and contribute to a balanced metabolic state.

It is often utilized alongside other prescribed antidiabetic compounds or insulin to offer a comprehensive approach to the condition. The ultimate purpose of its use is to support long-term well-being in individuals managing this chronic condition, which may help mitigate associated long-term complications. Consult a healthcare professional to determine if Diamed is an appropriate approach for your specific health requirements.

Eligibility for Diamed (Metformin Hydrochloride)

The official eligibility profile for Diamed is defined by regulatory authorities, classifying use based on physiological status and age.

Populations Permitted to Use: Use is allowed for adults, adolescents, and children aged 10 years and older diagnosed with Type 2 Diabetes Mellitus. The medicine is not for the treatment of Type 1 Diabetes.

Absolute Contraindications: The medicine must not be used in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis (including diabetic ketoacidosis or lactic acidosis), or hypersensitivity to the active ingredient. It is also strictly contraindicated in conditions causing tissue hypoxia (e.g., decompensated heart failure) and during acute alcohol intoxication or alcoholism.

Conditional and Restricted Use: Use requires dose adjustment and frequent monitoring in patients with moderate renal impairment (eGFR 30–89 mL/min). Metformin should generally be avoided in patients with hepatic impairment. For older adults (aged 80 and over), treatment should not be initiated without first confirming unreduced renal function. The medicine must be temporarily discontinued before certain surgical procedures and radiologic studies involving iodinated contrast media. Use during breastfeeding is not recommended as Metformin is excreted into human milk, and use during pregnancy requires careful risk assessment.

Interactions with other medicines and products

Diamed, containing Metformin Hydrochloride, has documented interaction patterns that primarily involve pharmacokinetics (drug levels) and pharmacodynamics (drug effects) according to regulatory labels.

Official Interaction Statements

Co-administration with Iodinated Contrast Media is officially classified as a contraindication and requires the medication to be temporarily withheld. This mandatory timing restriction addresses the risk of acute renal function changes, which can lead to Metformin accumulation and subsequent lactic acidosis.

Pharmacokinetic interactions occur with certain inhibitors of renal transporters (e.g., cimetidine, dolutegravir, ranolazine, trimethoprime). The inhibition of Organic Cation Transporters ( OCT2) reduces Metformin clearance, officially resulting in increased plasma concentration (exposure) and a heightened risk of accumulation.

In pharmacodynamic interactions, the use of Diamed alongside other glucose-lowering agents (such as insulin or sulfonylureas) has an additive effect, increasing the documented risk of hypoglycemia. Conversely, medicinal products with hyperglycaemic activity (e.g., glucocorticoids) may reduce its glucose-lowering efficacy.

Regarding substances, excessive alcohol intake is officially documented to potentiate the drug's effect on lactate metabolism, officially increasing the risk of lactic acidosis. Furthermore, the extent of absorption (AUC) of the extended-release formulation is officially documented to increase by approximately 50% when administered with food.

How Diamed Works: Mechanism of Action

Metformin Hydrochloride (Diamed) exerts its pharmacodynamic action through the modulation of fundamental energy pathways, primarily in the liver and peripheral tissues. The mechanism is initiated by the drug acting as an inhibitor of the Mitochondrial Respiratory Chain Complex I within hepatocytes. This molecular interaction shifts the cell’s AMP:ATP ratio, which serves as a signal for the profound activation of the AMP-activated protein kinase (AMPK) enzyme.

This cascade suppresses the metabolic pathways responsible for the creation of new glucose (gluconeogenesis), thereby reducing the liver’s overall glucose output into the bloodstream. Concurrently, the activation of the AMPK pathway in skeletal muscle enhances the responsiveness of these cells to existing circulating insulin. This action facilitates the uptake and utilization of glucose by peripheral tissues, thereby participating in the systemic glucose clearance process. This mechanism is distinct because it is not an insulin secretagogue, meaning it does not force the pancreatic beta-cells to secrete insulin.

How to Use Diamed — Administration Guidelines

The usage of Diamed (Metformin) follows specific administration requirements. The medicine is strictly for the oral route, available as both Immediate-Release (IR) and Extended-Release (ER) formulations.

Dosing and Frequency Patterns

Treatment is initiated with a low starting dose and is followed by a gradual dose adjustment (titration) over several weeks, based on individual requirements. For the IR tablet, the standard starting dose is typically 500 mg twice daily, with the maximum recommended daily dose ranging up to 2550 mg to 3000 mg in divided doses. The ER formulation is generally taken once daily, with a maximum daily dose of 2000 mg.

Administration Conditions and Constraints

Category	Administration Instruction
Timing with Food	IR tablets must be taken with or after meals for better tolerability. ER tablets are typically taken once daily with the evening meal.
Preparation	Extended-Release tablets must be swallowed whole and must not be crushed, cut, dissolved, or chewed.
Missed Dose	If a dose is missed, patients are instructed to not take a double dose and to simply resume the regimen at the next scheduled time.
Renal Constraints	Use is constrained by estimated glomerular filtration rate (eGFR). Dose adjustment or discontinuation is mandatory when eGFR falls below certain thresholds.

These instructions establish a standardized, controlled protocol for administration, ensuring consistency in the application of the treatment regimen.

Research evidence / Overview of studies for Diamed

This overview provides a non-advisory summary of the clinical research that has evaluated Metformin (Diamed), focusing on the types of studies conducted and what the evidence landscape shows, based on official regulatory and scientific sources. Research helps show what has been observed in large, studied populations, but findings describe group patterns, not personal outcomes.

---

Evidence for Use in Type 2 Diabetes Mellitus

Research exploring Metformin in adults with Type 2 Diabetes Mellitus primarily relies on Randomized Controlled Trials (RCTs) and comprehensive summaries of clinical data. These studies were used to examine measurements of biomarkers of blood sugar measurements, such as the HbA1c measure and Fasting Plasma Glucose, and the rate of long-term diabetes complications in adult populations. Findings describe patterns observed in these studies related to blood sugar measurements. Long-term observational settings also evaluated outcomes related to the body's systemic measures, such as the microvascular outcomes affecting the eyes and kidneys. While the evidence contributes to understanding symptom patterns and blood sugar measurements, the results apply only to the populations studied.

---

Evidence for Use in Preventing Type 2 Diabetes

The evidence base for Metformin's use in individuals at high risk for developing Type 2 Diabetes is supported by several pivotal RCTs. These studies explored short-term symptom changes and typically included adults diagnosed with prediabetes. The main research endpoints focused on tracking the incidence of Type 2 Diabetes diagnosis. Research so far explores how progression rates varied compared to placebo. Studies also observed that the patterns seen in the Metformin group were different from those seen with intensive lifestyle interventions. What remains uncertain in this area includes whether the findings are sustained indefinitely after treatment is discontinued.

---

Evidence in Specialized Patient Groups

For patients with moderately reduced kidney function (specifically an eGFR between 30 and 59 mL/min/1.73 m^2), the research examined outcomes related to the risk of lactic acidosis—a condition related to metabolic imbalance. Regulatory summaries reported a reassessment of the risk profile, while confirming that the risk profile for lactic acidosis was deemed unacceptable in research for patients with more severely reduced kidney function. Metformin was also studied for glycemic measurements in pediatric patients (typically aged 10 and older); data for this group remain insufficient compared to the large volume of research available for adults.

Key Studies & References

1. Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement

Common questions about Diamed (FAQ)

Q: What is Diamed and what is it used for?

Diamed is the brand name for the drug glimepiride, which belongs to a class of medications called sulfonylureas. It is an oral medication used to help control high blood sugar in people with Type 2 diabetes mellitus.

Diamed works by stimulating the pancreas to release more insulin, which is a hormone that helps move sugar from the blood into other body tissues where it is used for energy. It is typically used along with diet and exercise when those measures alone are not enough to manage blood sugar levels.

Q: How should I take Diamed?

Diamed is taken by mouth, usually once a day, with the first main meal of the day or shortly before it. Always follow the specific instructions provided by your healthcare provider.

• Do not crush, chew, or break the tablet. Swallow it whole.
• If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular schedule. Do not double your dose to make up for a missed one.
• It is crucial to continue following the diet and exercise plan recommended by your healthcare provider while taking Diamed.

Q: What are the most common side effects of Diamed?

The most common and significant side effect of Diamed is hypoglycemia (low blood sugar). This risk is increased if you skip meals, exercise heavily, or drink alcohol.

Symptoms of low blood sugar include:

• Shakiness or trembling
• Dizziness or lightheadedness
• Sweating
• Fast heartbeat
• Confusion or difficulty concentrating

Other common side effects may include:

• Nausea
• Diarrhea or stomach upset
• Headache
• Temporary vision changes, especially when starting treatment

Contact your healthcare provider if you experience symptoms of low blood sugar or any other side effects that are severe or do not go away.

Q: Can I drink alcohol while taking Diamed?

It is generally recommended to limit or avoid alcohol consumption while taking Diamed. Alcohol can increase the risk of hypoglycemia (low blood sugar).

Alcohol can interfere with how the body produces and uses sugar, making it more difficult to recognize and treat low blood sugar. Discuss your alcohol use with your healthcare provider to understand the specific risks based on your health status and medication dosage.

How to Store and Dispose of Diamed (Metformin Hydrochloride)

Official regulatory documents mandate strict storage and disposal requirements to maintain the product's integrity and safety.

Storage Conditions

Diamed must be stored at controlled room temperature, generally not exceeding 25°C or 30°C, and should be kept in a dry place. The medicine must remain in its original container, which should be kept tightly closed, and must be protected from moisture and excessive heat. It is essential to store the product out of the sight and reach of children.

Disposal Instructions

Unused or expired Diamed must be disposed of according to local regulations for pharmaceutical waste. Do not discard the medicine via household trash or flush it down the toilet or sink, as this can affect the environment. Use authorized drug take-back programs where available.